CE/CME No: CR-1309
Earn credit by reading this article and successfully completing the posttest. Successful completion is defined as a cumulative score of at least 70% correct.
• Discuss the central role that human papillomavirus (HPV) infection plays in the development of cervical intraepithelial neoplasia (CIN) and cervical cancer.
• Instruct patients on contributing cofactors of HPV infection and cervical cancer, including tobacco use, parity, use of oral contraceptives, co-infection with HIV, and immunosuppression.
• Describe the current recommendations for cervical cancer screening from professional societies, national health organizations, and federal agencies, including age-appropriate screening for cytology and high-risk HPV.
• Explain the timing and administration schedules of the currently available HPV vaccines and the patient populations for which the vaccines have been approved.
• Discuss the ablative and excisional procedures used to treat CIN and the treatment options for cervical cancer.
Heather P. Adams is an Assistant Professor/Clinical Coordinator in the Physician Assistant Program at Gannon University in Erie, Pennsylvania; in the program, Erica L. Carnright is a Physician Assistant student on clinical rotations.
The authors have no significant financial relationships to disclose.
Article begins on next page >>